𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

✍ Scribed by Steven A. Narod

Publisher
Springer US
Year
2011
Tongue
English
Weight
133 KB
Volume
128
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tamoxifen and contralateral breast cance
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
✍ Jacek Gronwald; Nadine Tung; William D. Foulkes; Kenneth Offit; Ruth Gershoni; M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 77 KB

## Abstract Women with a mutation in __BRCA1__ or __BRCA2__ face a lifetime risk of breast cancer of ∼80%, and following the first diagnosis the10‐year risk of contralateral breast cancer is ∼30%. It has been shown that both tamoxifen and oophorectomy prevent contralateral breast cancer, but it is

Lymphocyte radiosensitivity in BRCA1 and
Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility
✍ Julian Barwell; Laurent Pangon; Anne Georgiou; Ian Kesterton; Caroline Langman; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 336 KB πŸ‘ 1 views

## Abstract There is conflicting evidence as to whether individuals who are heterozygous for germ‐line __BRCA1__ or __BRCA2__ mutations have an altered phenotypic cellular response to irradiation. To investigate this, chromosome breakage and apoptotic response were measured after irradiation in per